Split and re-launched
We are receiving on a daily basis numerous inquiries concerning the regulated medicinal products (drugs, quasi-drugs, medical devices and cosmetics) and the regulatory affairs in Japan. To further make world-wide available the researched answers we have provided to the professional users and customers, a new interactive repository - Recentanswers has been re-launched as a blog. The Recentanswers Blog is an enhanced Frequently Asked Question (FAQ) system covering most of the queries and questions sent to the Regulatory Department of the JKS and to JKS in general. The answers not only address the issues, but also are extended to provide wider background information.
In contrast to Recentanswers blog, our other forum - Jouhoublog is preserved for the personal opinions of researchers and analysts working in the regulatory and business development fields. A number of events in the Japanese pharma industry warrant comments, especially the regulatory and procedural news what are largely ignored by the commercial news services.
All users and customers are encouraged to send queries for regulatory and other pharma, biotech and medical device issues by email to email@example.com.